Combination therapy of 177Lu and 90Y Dotatate for treatment of neuroendocrine cancer.
Affiliation
Department of Medical Physics, Royal United Hospital Bath NHS Trust, BathIssue Date
2014-02-19
Metadata
Show full item recordCitation
Combination therapy of 177Lu and 90Y Dotatate for treatment of neuroendocrine cancer. 2014: Nucl Med CommunJournal
Nuclear Medicine CommunicationsDOI
10.1097/MNM.0000000000000094PubMed ID
24556965Type
ArticleLanguage
enISSN
1473-5628ae974a485f413a2113503eed53cd6c53
10.1097/MNM.0000000000000094
Scopus Count
Collections
Related articles
- Ectopic Corticotropin-Producing Neuroendocrine Tumor of the Pancreas Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy.
- Authors: Makis W, McCann K, Riauka TA, McEwan AJ
- Issue date: 2016 Jan
- Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment.
- Authors: Parghane RV, Mitra A, Upadhye T, Rakshit S, Banerjee S, Basu S
- Issue date: 2020 Sep
- Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
- Authors: Kunikowska J, Królicki L, Hubalewska-Dydejczyk A, Mikołajczak R, Sowa-Staszczak A, Pawlak D
- Issue date: 2011 Oct
- Long-term results and tolerability of tandem peptide receptor radionuclide therapy with (90)Y/(177)Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.
- Authors: Kunikowska J, Pawlak D, Bąk MI, Kos-Kudła B, Mikołajczak R, Królicki L
- Issue date: 2017 Jun
- Different technical possibilities of post-therapeutic tandem 90Y/ /177Lu-DOTATATE imaging.
- Authors: Kunikowska J, Bajera A, Sawicka M, Czwarnowski P, Pawłowicz B, Aksamit D, Pawlak D, Królicki L
- Issue date: 2013